Sophiris Bio Inc.
1258 Prospect Street
La Jolla, CA 92037 USA
August 28, 2017
Via EDGAR
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ada D. Sarmento
|
RE: |
Sophiris Bio Inc. Registration Statement on Form S-3 Filed August 10, 2017 File No. 333-219887 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on August 30, 2017, or as soon thereafter as is practicable.
Thank you for your assistance. If you should have any questions, please contact Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157.
|
|
Sophiris Bio Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Peter T. Slover |
|
|
|
|
Peter T. Slover |
|
|
|
|
Chief Financial Officer |
|